Diakonos Oncology has dosed the first subject in its Phase II trial of investigational patient-derived double-loaded dendritic cell therapy, DOC1021, for treating a highly aggressive brain tumour, ...

Lymphoid-derived conventional dendritic cells (L-cDCs) may play a unique function associated with immune suppression and ...

Immune responses rely on the efficient movement of immune cells within the complex and geometrically unpredictable three-dimensional tissues that make up our bodies.

In a breakthrough study published in Cancer Immunology Research , scientists at the Icahn School of Medicine at Mount Sinai have developed a novel ...

Lymphoid-derived conventional dendritic cells (L-cDCs) may play a unique function associated with immune suppression and ...

Scientists have developed a novel method to generate billions of rare immune cells known as conventional type I dendritic ...

Sepsis-induced immune dysfunction is a major contributor to high mortality rates in septic patients. Recent findings shed light on the role of ...

Landmark preclinical data validate Renovaro's platform representing a step forward in the fight against pancreatic and solid ...

A Japanese research team led by the National Cancer Center Japan announced in the British journal Nature on June 14 that it ...

Cancer therapies called checkpoint inhibitor drugs, which ratchet up the immune system, work better when this bacterium is ...